|
The Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic held its second meeting and a public workshop on March 6-7, 2006 in the Auditorium of the NAS Building, located at 2101 Constitution Ave. N.W.-Washington D.C.
PowerPoint presentations are posted below the speaker's name. Online presentations from the workshop are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read in the National Academies LEGAL STATEMENT.
Board on Health Sciences Policy
The Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic
Meeting 2 and Workshop
March 6-7, 2006
The National Academies 2101 Constitution Ave. N.W., Washington, DC 20418 AUDITORIUM
AGENDA
Monday, March 6, 2006 NAS Auditorium
9:30 am Overview of the Workshop and the Committee’s Task
- John Bailar, Committee Co-Chair
Professor Emeritus University of Chicago
SESSION 1: OVERVIEW OF INFLUENZA AND RESPIRATORY PROTECTION
9:45 Presentation 1: Influenza Transmission and Pandemics
- Rashid A. Chotani, M.D., M.P.H.
Global Infectious Disease Surveillance & Alert System Johns Hopkins School of Public Health
10:15 Discussion
10:45 Presentation 2: Facemasks in Context for Fighting Flu - Health Care Workers and the General Public
- Richard L. Garwin, Ph.D.
IBM Fellow Emeritus
11:00 Discussion
11:30 Lunch
Panel 1: The Users’ Perspectives on Respiratory Protection
12:30 pm Global Health Perspective
- David Bell
Centers for Disease Control
12:45 Use of Masks in Asia During SARS
- Linda Chiarello
U.S. Centers for Disease Control
1:00 Health Care Worker Perspective
- Michael Bell
Centers for Disease Control
1:15 General Public Perspective - Key Questions Related To Reusable Facemasks
- Jeffrey Levi, Ph.D.
Senior Policy Advisor Trust for America's Health
1:30 Community Public Health System Perspective
- Jeff Durchin, M.D.
Chief, Communicable Disease Control, Epidemiology & Immunization Section Public Health--Seattle King County
1:45 Questions and General Discussion
SESSION 2: SURGICAL MASK PRODUCTION AND DESIGN
2:00 Surgical Facemasks: Materials and Design
2:15 Manufacturing Process, Production, and Capacity
- Stacey McCarver
Research Manager-Facial Protection Kimberly-Clark Corporation
2:30 The China Experience
- Jiang Jiang, M.D.
Beijing Health Department (via teleconference)
2:45 Questions and General Discussion
3:15 Break
SESSION 3: N95 RESPIRATOR PRODUCTION AND DESIGN
Panel 2: Respirator Production and Design
3:30 Fitting the N95
4:00 Design, Materials, and Components
- Robert Weber
3M
- Pierre Jean Messier
Triosyn
- Roger R. Forrest
National Product Sales Manager-Respiratory Bacou-Dalloz ISG
4:40 Manufacturing Process, Production and Capacity - Panel Discussion
- Julia Tremblay
Senior Director, Respiratory Protection Aereo Technologies
- Jeff Birkner
Moldex
- Robert Weber
3M
- Roger R. Forrest
National Product Sales Manager-Respiratory Bacou-Dalloz ISG
5:00 Questions and General Discussion
5:15 Open Testimony
- This time is reseverd for the public to make comments during this time. If you are interested in making a statement please contact Emily Ann Meyer at emeyer@nas.edu or (202) 334-3496.
5:30 Working Reception in the Auditorium Galleria
6:30 Reception Concludes
Tuesday, March 7, 2006 NAS Auditorium
8:30 Welcome Don Burke, Committee Co-Chair Associate Chair and director Disease Prevention and Control Program Johns Hopkins School of Public Health
SESSION 4: REUSABILITY OF MASKS AND RESPIRATORS
8:45 Evidence of Contamination
9:00 Decontamination and Cleaning - Halamine Chemistry and its Applications in Medical Textiles
- Gang Sun, Ph.D.
University of California, Davis
9:45 OSHA Perspective
- Andrew Levinson
Health and safety Specialist Directorate of Standards and Guidance, OSHA
- John Steelnack
Industrial Hygienist Directorate of Standards and Guidance, OSHA
10:30 Questions and General Discussion
11:00 Open testimony
- This time is reseverd for the public to make comments during this time. If you are interested in making a statement please contact Emily Ann Meyer at emeyer@nas.edu or (202) 334-3496.
11:30 Adjourn
|